AB | BC | MB | NB | NL | NS | NT | ON | PE | QC | SK | YT

News & Announcements

2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

July | June | May | Apr | Mar | Feb | Jan

Cannabis for Medical and Non-Medical Purposes: NAPRA Position Statement on the Role of Pharmacy Practitioners
July 05, 2017

NAPRA releases its position statement on cannabis for medical and non-medical purposes and the role of pharmacy practitioners.

Cannabis for Medical and Non-Medical Purposes: NAPRA Position Statement on the Role of Pharmacy Practitioners

La version française : Utilisation du cannabis à des fins médicales ou à des fins non médicales - Énoncé de position de l'ANORP sur le rôle des praticiens en pharmacie

Advisory
July 31, 2017

Unauthorized prescription drug "Selekta Pregnenolone" sold online by A.N. Tyler Distributing may pose serious health risks

Health Canada is advising Canadians that "Selekta Pregnenolone," an unauthorized prescription product sold online at www.antyler.com, may pose serious health risks. Health Canada seized the product from the company, A.N. Tyler Distributing. Selekta Pregnenolone was being promoted for anti-aging, arthritis, depression, menopause, mental fatigue, premenstrual syndrome, prostate disorders, skin irritation, scleroderma stress, women's health and supporting the immune system.

Health Canada Advisory

Health Product InfoWatch
July 28, 2017

Health Product InfoWatch

The July issue of the Health Product InfoWatch published by Health Canada is now available. This monthly publication provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products. Please consult the index for a complete listing of previous issues.

Advisory
July 27, 2017

Important safety information for people with diabetes using NovoPen Echo or NovoPen 5

Health Canada is advising Canadians that Novo Nordisk A/S has updated a voluntary recall of insulin cartridge holders used in certain lots of its NovoPen Echo and NovoPen 5 insulin pens. The company detected that the cartridge holders may crack or break if exposed to certain chemicals, such as some cleaning agents.

Health Canada Advisory

Foreign Product Alert
July 27, 2017

Foreign Product Alert

Health Canada is advising Canadians not to use these foreign health products as they may pose a health risk. These products have been found by regulators in other countries to contain prescription drugs, heavy metals, or unauthorized drugs that are not declared on the product label. Prescription drugs should only be taken under the supervision of a healthcare practitioner.

These products are not authorized for sale in Canada and have not been found on the Canadian market, but they may have been brought into the country by travellers or purchased over the Internet.

Big N Hard, Black Gorilla, Cummor, Dragon Max, Oh Baby!, Man XXX, Maxman IV, Maxman Premium, Maxman V, Monkey Business, MMC Maxman XI, MME Maxman IX capsules, New Advanced Technological, V9 Male Sexual Stimulant, Real Skill Male Sexual Stimulant, Rize N Shine, Tornado, Xrect, XXXL Penis Enlarging Ointment, Z Daily

Health Canada Foreign Product Alert

Advisory
July 19, 2017

Unauthorized natural health product promoted as a workout supplement, “Fluffy Unicorn” seized from Shop Santé Laval in Quebec

Health Canada is advising Canadians that the unauthorized natural health product promoted as a workout supplement “Fluffy Unicorn” may pose serious health risks. Health Canada laboratory testing found that the product contains undeclared synephrine, and higher levels of caffeine than declared on the label. In combination these ingredients can pose serious health risks. Health Canada seized the product from Shop Santé Laval in Laval, Quebec (329 Saint-Martin Blvd. W.).

Health Canada Advisory

Health Product Risk Communication
July 12, 2017

Important Safety Information on Shortage of Erwinase for Injection

ERWINASE product that is being distributed in Canada now has Canadian labelling and not UK labelling as mentioned in previous risk communications. Carefully inspect the reconstituted product. If you discover particulate matter do not administer the product and retain for collection. If there is no visible particulate matter after reconstitution, use a standard 5-micron filter needle to withdraw the reconstituted product from the vial prior to administration as an additional precaution.

Health Canada Health Product Risk Communication 

Advisory
July 10, 2017

Unauthorized sexual enhancement product “Black Mamba Premium” seized from JJ Smoke Centre in North York

Health Canada is advising Canadians that the unauthorized sexual enhancement product “Black Mamba Premium” may pose serious health risks because its label says it contains a drug called yohimbe. Health Canada seized the product from JJ Smoke Centre in North York, Ontario (5429 Yonge Street).

Health Canada Advisory

Advisory
July 10, 2017

Unauthorized kratom products seized from Culture Rising store in Milton, ON 

Health Canada is advising Canadians that it has seized several unauthorized kratom products from Culture Rising at 1248 Main St E, Milton, ON. Kratom may pose serious health risks when swallowed or inhaled.

Health Canada Advisory

Advisory
July 10, 2017

Bayer expands recall of RestoraLAX, sold nationwide, due to potential choking hazard

Further to a recent recall of RestoraLAX 45+10, Health Canada is advising Canadians that Bayer Inc. is expanding its voluntary recall to include specific lots of RestoraLAX 30+7 Bonus Packs sold at various retailers across Canada due to a potential choking hazard. 

Health Canada Advisory

Advisory
July 04, 2017

Unauthorized sexual enhancement product “Rhino 69 Extreme 10K” seized from Riverdale Trading Company in Toronto

Health Canada is advising Canadians that the unauthorized sexual enhancement product “Rhino 69 Extreme 10K” may pose serious health risks because its label says that it contains a prescription drug (yohimbe extract (bark)).

Health Canada Advisory

Advisory
July 04, 2017

Authorized Canadian naloxone Nasal Spray (NARCAN) coming to market

Health Canada is advising health care professionals and Canadians that the Canadian authorized version of NARCAN will transition onto the market by July 5, 2017. NARCAN is a nasal spray form of naloxone, the life-saving drug that temporarily reverses the effects of an opioid overdose.

NARCAN is the same product in Canada and the U.S. Minor labelling differences are the only distinctions between the Canadian and American versions of the product.

Health Canada Advisory

Advisory
July 04, 2017

RestoraLAX 45 + 10 Value Pack sold at Costco Canada recalled due to potential choking hazard

Health Canada is advising Canadians that Bayer Inc. is voluntarily recalling RestoraLAX 45 + 10 Value Pack sold at Costco Canada due to a potential choking hazard. The recalled product may contain deposits such as clumps or lumps.‎ The presence of these deposits may pose a choking hazard.

Health Canada Advisory

Health Product Risk Communication
July 04, 2017

Important Safety Information on Gentamicin Injection USP (10 mg/mL and 40 mg/mL) – Potential for Adverse Reactions with 12 Lots Contaminated with Histamine

Twelve lots of Gentamicin Injection USP manufactured at Sandoz Canada Inc. may contain traces of histamine. Healthcare professionals are advised, when administering Gentamicin Injection USP, to closely monitor all patients for adverse reactions associated with elevated levels of histamine.

Health Canada Health Product Risk Communication